CA3295270A1 - Diagnosis or prognosis of postsurgical adverse events - Google Patents

Diagnosis or prognosis of postsurgical adverse events

Info

Publication number
CA3295270A1
CA3295270A1 CA3295270A CA3295270A CA3295270A1 CA 3295270 A1 CA3295270 A1 CA 3295270A1 CA 3295270 A CA3295270 A CA 3295270A CA 3295270 A CA3295270 A CA 3295270A CA 3295270 A1 CA3295270 A1 CA 3295270A1
Authority
CA
Canada
Prior art keywords
postsurgical
prognosis
diagnosis
adverse events
adverse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3295270A
Other languages
English (en)
Inventor
Michelle Chew
Henrik Andersson
Darius WILSON
Original Assignee
BRAHMS GmbH
Linkoping University Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRAHMS GmbH, Linkoping University Hospital filed Critical BRAHMS GmbH
Publication of CA3295270A1 publication Critical patent/CA3295270A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA3295270A 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events Pending CA3295270A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19020082 2019-02-21
EP19020082.4 2019-02-21
CA3126202A CA3126202A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA3126202A Division CA3126202A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events

Publications (1)

Publication Number Publication Date
CA3295270A1 true CA3295270A1 (en) 2026-03-02

Family

ID=65529223

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3295270A Pending CA3295270A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events
CA3126202A Pending CA3126202A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3126202A Pending CA3126202A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events

Country Status (7)

Country Link
US (1) US20220187313A1 (https=)
EP (1) EP3928099A1 (https=)
JP (2) JP2022521390A (https=)
CN (1) CN113424065A (https=)
BR (1) BR112021016597A2 (https=)
CA (2) CA3295270A1 (https=)
WO (1) WO2020169819A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240221958A1 (en) * 2021-04-30 2024-07-04 Roche Diagnostics Operations, Inc. Pct marker panels for early detection of sepsis
WO2022229438A2 (en) * 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Il6 marker panels for early detection of sepsis
EP4351636A4 (en) * 2021-06-02 2025-04-23 Washington University Systems and methods for multimodal analysis of surgical drain fluid using interchangeable and customizable nucleic acid based tests
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
JP2023111774A (ja) * 2022-01-31 2023-08-10 国立研究開発法人国立循環器病研究センター 再灌流療法の適用を決定するバイオマーカー
KR20250077078A (ko) * 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심장 트로포닌 수치를 예측하기 위한 방법 및 장치
KR20250077079A (ko) 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심근 손상을 예측하기 위한 방법 및 장치
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement
KR102750097B1 (ko) * 2024-07-29 2025-01-03 가천대학교 산학협력단 심혈관 시술 이후 환자의 합병증 예측 및 추적 관리 시스템 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US9012151B2 (en) * 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
JP5711131B2 (ja) * 2008-10-07 2015-04-30 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最初の有害事象の予測のためのバイオマーカー
WO2014018464A1 (en) * 2012-07-23 2014-01-30 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
GB201402293D0 (en) * 2014-02-11 2014-03-26 Secr Defence Biomarker signatures for the prediction of onset of sepsis
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
JP6855118B2 (ja) * 2017-03-14 2021-04-07 東ソー株式会社 全身状態の良不良を評価するための情報を提供する方法及び測定試薬
EP3438668A1 (en) * 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections

Also Published As

Publication number Publication date
JP2025019061A (ja) 2025-02-06
CN113424065A (zh) 2021-09-21
BR112021016597A2 (pt) 2021-11-03
CA3126202A1 (en) 2020-08-27
US20220187313A1 (en) 2022-06-16
JP2022521390A (ja) 2022-04-07
WO2020169819A1 (en) 2020-08-27
EP3928099A1 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
CA3295270A1 (en) Diagnosis or prognosis of postsurgical adverse events
EP3932021A4 (en) SECURE BLOCKCHAIN-BASED EMAIL SYSTEM
EP4130905A4 (en) VISUALIZATION SYSTEM
CA3286688A1 (en) Novel crystalline forms
EP3943015A4 (en) ANCHOR INSTRUMENT
EP3998262A4 (en) NRF2 ACTIVATING COMPOUND
EP3997816A4 (en) VLAN-AWARE CLOCK HIERARCHY
EP3932682A4 (en) CASSETTE
EP3995263A4 (en) POSITIONING PLATE
EP4031012A4 (en) PROBE PROTECTOR
CA3292624A1 (en) Cassette
EP3885566A4 (en) POETRY
HK40064706A (en) Diagnosis or prognosis of postsurgical adverse events
EP3988752A4 (en) Hardware mounting structure
EP3998750A4 (en) SIGNAL PROCESSOR
EP3889170A4 (en) BIOMARKERS FOR DIAGNOSIS OF A MENTAL CONDITION AT RISK
HK40069758A (en) Knowledge proof
HK40072689A (zh) 知识证明
TWI923945B (zh) 嗒基-噻唑甲醯胺化合物
TWI923944B (zh) 嗒基-噻唑甲醯胺化合物
HK40072323A (en) Pan-neuraminidase inhibiting antibodies
EP4026115A4 (en) DISPLAY ARRANGEMENT
EM74971770001S (cs) Teploměry [včetně lékařských]
HK40062060A (en) Blockchain-based secure email system
AU2019900482A0 (en) Construction panel manufacture

Legal Events

Date Code Title Description
A16 Divisional, continuation or continuation in part application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A16-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - DIVISIONAL

Effective date: 20251210

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20251210

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251210

A18 Application divided or continuation or continuation in part accepted

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A18-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DIVISIONAL REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260113

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260113

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260113

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260113

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20260121

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-P146 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: BSL VERIFIED - NO DEFECTS

Effective date: 20260121

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20260216

P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20260216

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-2-2-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION)

Effective date: 20260302